Discover What Stanford Medicine Has Unveiled: Breakthroughs and Innovations in Healthcare

Unraveling the Dynamics of Aging: Insights from Stanford Medicine Recent research from Stanford Medicine reveals significant changes in the molecules and microorganisms within our bodies at ages 40 and 60. These shifts, akin to biological metamorphoses, were tracked through extensive analysis of thousands of molecules and microbes in individuals ranging from 25 to 75 years … Read more

New drug mimics low-oxygen treatment for Leigh Syndrome

The Future of Low-Oxygen Therapies: From Mountains to Pills Living at high altitudes has long been associated with certain health benefits, such as a reduced risk of heart disease and enhanced endurance, thanks to the thinner air and lower oxygen levels. But for individuals with inherited mitochondrial diseases, specifically Leigh Syndrome, breathing low-oxygen environments could … Read more

New mechanism regulates the immune response against parasites

The Hidden Defenders: Immune Regulation Against Parasitic Infections New research from the University of Liège in Belgium has shed light on an innovative immune mechanism regulating responses against parasitic infections. By focusing on virtual memory T cells (TVM), scientists have discovered how these cells help keep inflammation in check with a surprising twist involving the … Read more

Duke engineers develop AI platform to target undruggable disease proteins

Spearheading a Revolution in Biomedical Engineering: The Future of Therapeutics Recent developments from Duke University have ushered in a groundbreaking era in biomedical engineering, with the creation of an AI-based platform designed to craft short proteins, known as peptides, that can target and deactivate complex disease-causing proteins previously deemed undruggable. This innovation, aptly named PepPrCLIP, … Read more

Study identifies potential pathway to improve memory in neurodegenerative diseases

The Future of Treating Neurodegenerative Diseases: A Leap Forward Groundbreaking research from the UPV/EHU’s Neurochemistry and Neurodegeneration group has unveiled promising new avenues for treating cognitive impairment in Alzheimer’s and Parkinson’s diseases. The study, led by Dr. Rafael Rodríguez-Puertas and Marta Moreno-Rodríguez, highlights how the cannabinoid and cholinergic systems in the brain could work together … Read more